STEPHEN HUANG

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PASADENA, CA NPI 1124089685

General Payments — all program years on this page

$10,632.92

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 394
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $766.02 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $766.0213

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Janssen Biotech, Inc. $151.972
Incyte Corporation $140.001
Rigel Pharmaceuticals, Inc. $120.211
JAZZ PHARMACEUTICALS INC. $117.501
Mirati Therapeutics, Inc. $89.522
ABIOMED $59.182
ABBVIE INC. $27.531
ImmunoGen, Inc. $25.841
Novocure Inc. $17.771
BeiGene USA, Inc. $16.501

By program year

Program yearAmountRecords
2018 $3,269.16151
2019 $3,608.27168
2020 $965.0841
2021 $1,031.0210
2022 $623.865
2023 $369.516
2024 $766.0213

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078317284 Janssen Biotech, Inc. $26.97 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078317372 Janssen Biotech, Inc. $125.00 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099941587 ImmunoGen, Inc. $25.84 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103948490 ABBVIE INC. $27.53 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117161055 Mirati Therapeutics, Inc. $44.76 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117161059 Mirati Therapeutics, Inc. $44.76 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120864440 BeiGene USA, Inc. $16.50 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123338971 Novocure Inc. $17.77 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141192425 Incyte Corporation $140.00 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142309681 ABIOMED $26.80 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142309683 ABIOMED $32.38 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145198603 Rigel Pharmaceuticals, Inc. $120.21 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150200187 JAZZ PHARMACEUTICALS INC. $117.50 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.